Literature DB >> 8908699

Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens.

P Romero1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8908699     DOI： 10.1007/bf00820665

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  79 in total

Review 1.  Genes coding for tumor antigens recognized by cytolytic T lymphocytes.

Authors:  A Van Pel; P van der Bruggen; P G Coulie; V G Brichard; B Lethé; B van den Eynde; C Uyttenhove; J C Renauld; T Boon
Journal:  Immunol Rev       Date:  1995-06       Impact factor: 12.988

Review 2.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

Authors:  G E Peoples; P S Goedegebuure; R Smith; D C Linehan; I Yoshino; T J Eberlein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

Review 4.  T-cell repertoire diversity and clonal expansions in normal and clinical samples.

Authors:  C Pannetier; J Even; P Kourilsky
Journal:  Immunol Today       Date:  1995-04

5.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Authors:  T Wölfel; M Hauer; J Schneider; M Serrano; C Wölfel; E Klehmann-Hieb; E De Plaen; T Hankeln; K H Meyer zum Büschenfelde; D Beach
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

6.  Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor.

Authors:  J P Levraud; C Pannetier; P Langlade-Demoyen; V Brichard; P Kourilsky
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

7.  A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

Authors:  J Herman; P van der Bruggen; I F Luescher; S Mandruzzato; P Romero; J Thonnard; K Fleischhauer; T Boon; P G Coulie
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

8.  The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.

Authors:  S Vijayasaradhi; B Bouchard; A N Houghton
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

9.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Authors:  P G Coulie; V Brichard; A Van Pel; T Wölfel; J Schneider; C Traversari; S Mattei; E De Plaen; C Lurquin; J P Szikora; J C Renauld; T Boon
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  2 in total

1.  High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.

Authors:  M J Pittet; D Valmori; P R Dunbar; D E Speiser; D Liénard; F Lejeune; K Fleischhauer; V Cerundolo; J C Cerottini; P Romero
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

2.  Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.

Authors:  P Romero; P R Dunbar; D Valmori; M Pittet; G S Ogg; D Rimoldi; J L Chen; D Liénard; J C Cerottini; V Cerundolo
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.